Medical Device Quality Management System (QMS)
A medical device quality management system is the foundation of every FDA clearance, ISO 13485 certification, and EU MDR approval your company will ever earn. Traccglobal helps US manufacturers build, fix, and maintain a QMS that works — not just on paper, but under real FDA inspections.
FDA QMSR (2026) Ready
ISO 13485:2016 Certified Consulting
EU MDR / EU IVDR Compliant
MDSAP Audit Support
USA-Based Regulatory Expertise
Quick Answer — Optimized for AI Overviews
A medical device quality management system (QMS) is a structured framework of documented policies, processes, and procedures that ensures medical devices are designed, manufactured, and monitored safely throughout their lifecycle. In the United States, a QMS for medical devices must now comply with the FDA’s Quality Management System Regulation (QMSR), effective February 2, 2026, which incorporates ISO 13485:2016 by reference, replacing most of the old 21 CFR Part 820 (QSR). Core processes of a medical device QMS include document control, CAPA management, risk management (ISO 14971), design controls, supplier management, internal audits, complaint handling, and post-market surveillance. Traccglobal provides end-to-end QMS consulting for US-based medical device manufacturers seeking FDA compliance, ISO 13485 certification, and EU MDR approval.
What Is a Medical Device Quality Management System?
A medical device quality management system is not just a binder of SOPs sitting on a shelf. It is the living, operational backbone of how your company designs, builds, monitors, and improves every device it sells. Without a properly implemented QMS for medical devices, you cannot legally market in the United States, Europe, or most major global markets.
Simply put, a medical device QMS documents what your organization does, controls how it does it, and provides proof that you actually did it — consistently and safely. From the earliest design sketches to post-market complaint reports, every step is captured, controlled, and traceable.
The FDA’s new Quality Management System Regulation (QMSR), effective February 2, 2026, now legally mandates that US manufacturers align with ISO 13485:2016 — the same global standard that governs medical device quality in over 100 countries. This is the most significant shift in US device quality regulation in nearly 30 years, and Traccglobal helps companies navigate this transition confidently.
Companies that treat their medical device quality management system as a compliance checkbox routinely face 483 observations, warning letters, and costly product recalls. Companies that build it right — with experienced consultants — turn it into a competitive advantage that speeds up product launches and opens new markets.
Critical 2026 Update
The FDA does not treat software like hardware. The FDA assumes that if software can fail, it will fail. This means your software design must plan for failure at every level — with redundancy, isolation of critical functions, and a fully traceable risk management file.
Core Processes of a Medical Device QMS
Every compliant medical device quality management system is built on these interconnected processes. Weakness in any single area creates audit risk across the whole system. Traccglobal’s consultants assess, build, and strengthen each of these areas.
Document Control
Manages creation, review, approval, versioning, and retirement of all QMS documents — SOPs, work instructions, forms, and records — ensuring only current, approved documents are in use during inspections.
Change Management
Controls every modification to design, materials, processes, and documentation with formal impact assessment. Prevents unauthorized changes that can trigger recalls or FDA 483 observations.
Training Management
Ensures all personnel are competent to perform their QMS responsibilities through role-based training, competency verification, and documented training records ready for audit review.
Nonconformance (NCR) Management
Captures and resolves deviations from product specifications or process requirements, with documented root cause investigation and CAPA linkage to prevent recurrence.
CAPA Management
Systematic corrective and preventive action processes — the heart of any effective QMS for medical devices. Includes 5-Why, Fishbone analysis, effectiveness verification, and audit trail documentation.
Complaint Handling
Structured intake, investigation, and resolution of customer complaints. Includes mandatory Medical Device Reporting (MDR) to the FDA and EU Vigilance reporting under MDR 2017/745.
Audit Management
Internal audits, supplier audits, and external regulatory inspection readiness — planned, executed, and documented to demonstrate continuous QMS effectiveness to the FDA and notified bodies.
Supplier Management
Qualification, evaluation, and ongoing monitoring of critical suppliers — including Approved Supplier List (ASL) maintenance, supplier audits, and CAPA management for supplier nonconformances.
Risk Management (ISO 14971)
End-to-end risk management from initial hazard identification through post-market risk updates. FMEA, risk control, residual risk acceptance, and Risk Management File (RMF) development.
Design Controls
Structured design and development process covering inputs, outputs, reviews, verification, validation, and transfer to manufacturing — including DHF, DMR, and DHR documentation required by the FDA QMSR.
Post-Market Surveillance (PMS)
Systematic collection and analysis of real-world device performance data after market launch, driving proactive risk updates, FSCA decisions, vigilance reporting, and PMCF under EU MDR.
Equipment & Calibration Management
Ensures all manufacturing and inspection equipment is qualified, calibrated, and maintained with documented records — preventing deviations that could affect product quality and regulatory compliance
QMS Documentation Hierarchy for Medical Devices
A well-structured medical device QMS follows a pyramid documentation model. Each level feeds down to the next — and every level must be audit-ready at all times. Traccglobal develops all five tiers of QMS documentation for medical device companies.
Quality Manual
Top-level document defining QMS scope, structure, and organizational framework aligned with ISO 13485 / FDA QMSR
Quality Policy & Objectives
Management commitment statements defining measurable quality goals, regulatory compliance pledges, and organizational values
Standard Operating Procedures (SOPs)
Process-level instructions for every core QMS function: document control SOP, CAPA SOP, audit SOP, complaint handling SOP, and more
Work Instructions (WIs)
Step-by-step task instructions for specific operations — child documents linked to parent SOPs for precise process execution
Records, Forms & Logs
Evidence of compliance: training records, audit reports, NCR logs, CAPA records, calibration certificates, DHF/DMR/DHR, complaint files
Regulatory Requirements for a Medical Device QMS in 2026
The regulatory landscape for QMS medical device compliance has changed significantly in 2026. Here’s what US and global manufacturers must know right now.
FDA QMSR (21 CFR Part 820) — Effective Feb 2, 2026
The most significant US device quality regulation update in 30 years. The new QMSR replaces the legacy QSR by incorporating ISO 13485:2016 by reference. FDA inspectors now use a new risk-based inspection process (CP 7382.850) instead of the old QSIT method. Companies that haven't transitioned their medical device quality management system to ISO 13485 language and structure are at immediate inspection risk.
ISO 13485:2016 — The Global QMS Standard
ISO 13485 is now effectively the law in the US (via QMSR) and is mandatory or strongly recommended in the EU, Canada (MDSAP), Australia (TGA), and Japan. It defines a risk-based approach to quality management covering design, production, distribution, and post-market activities. Traccglobal delivers ISO 13485 gap assessments, SOP development, and full certification support.
EU MDR 2017/745 — Medical Devices
The EU Medical Device Regulation demands a comprehensive medical device QMS as a prerequisite for CE marking. It introduces stricter clinical evaluation requirements, post-market clinical follow-up (PMCF), Unique Device Identification (UDI), and enhanced notified body scrutiny. US companies exporting to the EU must align their QMS with both FDA QMSR and EU MDR simultaneously.
EU IVDR 2017/746 — In Vitro Diagnostics
Manufacturers of IVD devices face a risk-based classification system (Class A–D) under EU IVDR, with dramatically increased notified body involvement for higher-risk devices. The regulation mandates robust clinical performance evaluation, PMS, and UDI implementation — all supported by a fully compliant medical device quality management system.
How to Implement a Medical Device QMS: Traccglobal's Proven Approach
Most companies underestimate how long QMS implementation takes. Industry data shows it averages 18–20 months to achieve ISO 13485 certification. Traccglobal’s structured approach compresses this timeline without cutting corners.
Regulatory Requirement Identification & Gap Assessment
Identify which regulatory frameworks apply to your products and markets — FDA QMSR, ISO 13485, EU MDR, MDSAP, or a combination. Traccglobal conducts a thorough gap assessment of your current quality system against all applicable requirements, producing a prioritized remediation roadmap so you know exactly what to fix and in what order.
Define Quality Policy, Objectives & QMS Scope
Establish management commitment with a clear quality policy and SMART quality objectives. Define exactly which products, processes, and facilities fall within QMS scope. Ambiguity here is the root cause of many failed audits — Traccglobal ensures your scope statement is precise and defensible.
Develop Quality Manual & Core QMS Documentation
Build a complete documentation hierarchy: Quality Manual, policies, SOPs, work instructions, and record templates. Traccglobal's consultants have written hundreds of ISO 13485 and FDA QMSR-compliant SOPs across document control, CAPA, design controls, risk management, and more — and we adapt them to your specific operations, not just generic templates.
Implement eQMS Software (If Applicable)
Choose and validate an electronic Quality Management System (eQMS) to digitize document control, training, CAPA, and audit management. For companies subject to FDA 21 CFR Part 11, the eQMS must be validated for electronic records and signatures. Traccglobal provides vendor-neutral eQMS selection guidance and full validation support.
Risk Management Program (ISO 14971)
Establish a device-specific risk management framework covering hazard identification, risk estimation, FMEA, risk control measures, residual risk evaluation, and post-production risk monitoring. Your Risk Management File (RMF) is a critical submission artifact for FDA 510(k) and EU MDR conformity assessments.
Employee Training on QMS & Regulatory Requirements
Role-based training ensures every team member understands their QMS responsibilities — from the shop floor operator following a work instruction to the quality manager handling a regulatory inquiry. Training records must be complete and current before any FDA inspection or notified body audit.
Supplier Qualification & Approved Supplier List (ASL)
Qualify and monitor all critical suppliers through documented evaluations, questionnaires, and on-site audits. Maintain a living Approved Supplier List that is reviewed at defined intervals. Supplier-related nonconformances must be addressed through formal CAPA with documented effectiveness checks.
Internal Audits, Management Reviews & Continuous Improvement
Conduct periodic internal audits to verify QMS effectiveness and identify improvement opportunities before external inspectors do. Annual management reviews assess KPIs, audit findings, complaint trends, and CAPA outcomes. Traccglobal can serve as your external internal audit team — providing independent, experienced eyes on your quality system.
Case Study: QMS Implementation for a US Medical Device Startup
From Zero QMS to ISO 13485 Certified in 14 Months
A US-based surgical instrument startup came to Traccglobal with no existing quality system, a pending FDA 510(k) submission, and a hard deadline driven by their distribution partner’s requirements. Their team of 12 had zero prior QMS experience, and they had already spent 6 months attempting to build the system internally — with nothing to show for it.
Traccglobal’s consultants conducted a day-one gap assessment against ISO 13485:2016 and FDA QMSR requirements, then built a complete QMS from scratch: 34 SOPs, a full Quality Manual, risk management documentation for 3 device families using ISO 14971 FMEA, supplier qualification for 8 critical suppliers, a validated eQMS platform, and a complete internal audit program.
We trained their entire team, managed their first internal audit cycle, and prepared their team for the ISO 13485 certification audit — which they passed with zero major nonconformances on the first attempt. Their FDA 510(k) submission was cleared 4 months after certification, and they successfully launched in the US market on schedule.
14 mo
Zero QMS → ISO 13485 Certified
0
Major nonconformances at certification audit
510(k)
FDA cleared — 4 months post-certification
Why Medical Device Companies Choose Traccglobal
There are dozens of QMS consultants. Here’s what makes Traccglobal different — and why it matters when your FDA inspection or ISO certification is on the line.
Medical Device-Specific Expertise
Traccglobal focuses exclusively on medical devices and IVDs — not generic ISO consulting. Our consultants have hands-on experience with 510(k), PMA, CE marking, and CDSCO submissions, which means we know what regulators actually look for during inspections.
QMSR-Ready Systems Built for 2026
Every QMS Traccglobal builds or remediates is structured for the new FDA QMSR (effective February 2026). We don't retrofit old 21 CFR 820 language — we build systems that align natively with ISO 13485:2016 so you're ready for the new inspection paradigm from day one.
Complete QMS Documentation Suite
From Quality Manual to the last record template, Traccglobal delivers every document your QMS needs — customized to your products, processes, and facilities. We don't hand you generic templates and wish you luck. We write, review, and finalize documentation alongside your team.
Multi-Market Compliance in One QMS
Most device companies sell in more than one market. Traccglobal architects your medical device quality management system to satisfy FDA QMSR, ISO 13485, EU MDR, and MDSAP simultaneously — eliminating the cost and confusion of parallel quality systems.
Data Integrity & eQMS Validation
Electronic records in the medical device industry must comply with FDA 21 CFR Part 11 and EU Annex 11. Traccglobal guides eQMS software selection, system configuration, and validation documentation — ensuring your digital quality records hold up under regulatory scrutiny.
Audit Preparation & Inspection Readiness
Traccglobal's consultants have participated in and prepared companies for hundreds of FDA inspections, notified body audits, and MDSAP assessments. We conduct pre-audit readiness reviews and mock inspections so your team is confident — not caught off-guard — when the auditor walks in.
Medical Device QMS vs. Pharmaceutical QMS — Key Differences
Many companies wonder whether the same quality system can serve both medical devices and pharmaceutical products. The answer is: not without significant adaptation. Here’s how they differ.
| Dimension | Medical Device QMS | Pharmaceutical QMS |
|---|---|---|
| Primary US Regulation | FDA QMSR / 21 CFR Part 820 (ISO 13485) | 21 CFR Parts 210 & 211 (cGMP) |
| Global Standard | ISO 13485:2016 | ICH Q10, EU GMP, WHO GMP |
| Design Controls | ✔ Mandatory (DHF, DMR, DHR) | Not typically required |
| Risk Management | ✔ ISO 14971 mandatory | ICH Q9 (pharmaceutical risk) |
| Post-Market Surveillance | ✔ Mandatory (EU MDR/IVDR, FDA) | Pharmacovigilance (ADR reporting) |
| Unique Device Identification | ✔ UDI required (FDA & EU) | Not applicable |
| Key Records | DHF, DMR, DHR, Technical File | Batch records, CoA, stability studies |
| Traccglobal Service Available | ✔ Full QMS consulting | ✔ Pharma QMS services |
Frequently Asked Questions
Frequently Asked Questions About Medical Device QMS
These are the most searched questions about QMS for medical devices — answered clearly and accurately by Traccglobal’s regulatory experts.
What is a medical device quality management system (QMS)?
What is the difference between ISO 13485 and FDA 21 CFR Part 820 QMSR?
ISO 13485:2016 is an international standard for medical device quality management systems, accepted in over 100 countries. FDA 21 CFR Part 820, now titled the Quality Management System Regulation (QMSR) effective February 2, 2026, is the US federal regulation that now incorporates ISO 13485:2016 by reference. In practical terms, this means ISO 13485 is now functionally the law in the US. However, the QMSR retains some FDA-specific additions — such as explicit references to MDR reporting (21 CFR Part 803), UDI (21 CFR Part 830), and certain record retention requirements — that go beyond ISO 13485. Companies certified to ISO 13485 still need to review their QMS for QMSR-specific additions.
How long does it take to implement a QMS for medical devices?
Industry data shows that ISO 13485 certification typically takes 18–20 months on average, with EU notified bodies often requiring over a year just to issue quality system certificates. However, with experienced QMS consultants like Traccglobal, this timeline can be compressed significantly. Companies with some existing quality infrastructure can often achieve certification in 10–14 months. For startups building from zero, 14–18 months is realistic when working with a dedicated consulting team. The key factors affecting timeline are: current QMS maturity, number of product families, complexity of manufacturing processes, and responsiveness of the certification body.
Do I need QMS software (eQMS) for a medical device company?
You are not legally required to use medical device QMS software — paper-based systems are still permitted. However, for companies of any meaningful size, a paper QMS creates enormous audit risk through version control failures, missing training records, and untraceable document approvals. Electronic quality management systems (eQMS) automate workflows, maintain complete audit trails, and dramatically reduce the time needed to retrieve records during FDA inspections. If you choose an eQMS, it must comply with FDA 21 CFR Part 11 requirements for electronic records and electronic signatures — and the system itself must be validated per FDA and ISO 13485 requirements. Traccglobal helps companies select and validate eQMS platforms that fit their size and regulatory profile.
What does the FDA QMSR mean for medical device manufacturers in 2026?
The FDA’s Quality Management System Regulation (QMSR) became effective and enforceable on February 2, 2026. It amends 21 CFR Part 820 by incorporating ISO 13485:2016 by reference, making it the functional legal standard for US medical device quality management systems. The FDA has simultaneously introduced a new risk-based inspection process (CP 7382.850), replacing the old Quality System Inspection Technique (QSIT). For manufacturers, this means: (1) your QMS documentation must align with ISO 13485 terminology and structure, (2) FDA inspectors will now look for risk-based thinking embedded throughout your system — not just in design controls, and (3) companies that relied on legacy 21 CFR 820 structures without ISO 13485 alignment face elevated inspection risk. Traccglobal recommends a QMSR gap assessment as an immediate first step.
What are the most common reasons medical device QMS audits fail?
The most common QMS audit failures in medical device companies include: (1) incomplete or inadequate CAPA systems — root causes not properly identified, effectiveness not verified; (2) document control failures — outdated SOPs still in use, missing approval signatures, poor version control; (3) inadequate design controls — DHF incomplete, design verification/validation not properly documented; (4) training records gaps — employees working without documented training on current procedures; (5) supplier qualification deficiencies — critical suppliers not formally qualified or monitored; (6) post-market surveillance system either missing or not generating meaningful data; and (7) risk management files incomplete or not updated after post-market findings. Traccglobal’s pre-audit readiness review specifically targets these high-risk areas.
Can the same QMS work for both FDA and EU MDR compliance?
Yes — an ISO 13485:2016-based QMS is the foundation for both FDA QMSR compliance and EU MDR / EU IVDR compliance. Since ISO 13485 is now incorporated by reference into the FDA QMSR, a single well-designed quality management system for medical devices can satisfy both jurisdictions with targeted additions. Key EU MDR-specific requirements that go beyond ISO 13485 include: Post-Market Clinical Follow-Up (PMCF), more detailed clinical evaluation documentation, stricter UDI requirements, Qualified Person for Regulatory Compliance (QPRC), and specific technical documentation structure. Traccglobal specializes in building integrated QMS architectures that satisfy FDA QMSR, ISO 13485, EU MDR, and MDSAP requirements simultaneously.
Ready to Build or Fix Your Medical Device Quality Management System?
Whether you’re starting from scratch, preparing for an FDA inspection, or transitioning to the new QMSR requirements — Traccglobal’s experts are ready to help. Get a free, no-obligation QMS assessment today.